FOXP3 and metabolic dysfunction-associated steatotic liver disease: Patients with a NAFLD activity score (NAS) greater than four have a higher number of areas of CD68-positive cells and forkhead box P3 (Foxp3)-positive cells than non-NASH patients [27].